AU2006213922B2 - Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use - Google Patents

Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use Download PDF

Info

Publication number
AU2006213922B2
AU2006213922B2 AU2006213922A AU2006213922A AU2006213922B2 AU 2006213922 B2 AU2006213922 B2 AU 2006213922B2 AU 2006213922 A AU2006213922 A AU 2006213922A AU 2006213922 A AU2006213922 A AU 2006213922A AU 2006213922 B2 AU2006213922 B2 AU 2006213922B2
Authority
AU
Australia
Prior art keywords
formula
substance
compound
less
metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006213922A
Other languages
English (en)
Other versions
AU2006213922A1 (en
AU2006213922A2 (en
Inventor
Maurice Sydney Newton
Nigel Peter Rhodes
Alexis John Toft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytochroma Development Inc
Original Assignee
Cytochroma Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytochroma Development Inc filed Critical Cytochroma Development Inc
Publication of AU2006213922A1 publication Critical patent/AU2006213922A1/en
Publication of AU2006213922A2 publication Critical patent/AU2006213922A2/en
Assigned to INEOS HEALTHCARE LIMITED reassignment INEOS HEALTHCARE LIMITED Alteration of Name(s) of Applicant(s) under S113 Assignors: INEOS SILICAS LIMITED
Application granted granted Critical
Publication of AU2006213922B2 publication Critical patent/AU2006213922B2/en
Assigned to CYTOCHROMA DEVELOPMENT INC. reassignment CYTOCHROMA DEVELOPMENT INC. Request for Assignment Assignors: INEOS HEALTHCARE LIMITED
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Iron (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2006213922A 2005-02-10 2006-02-09 Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use Ceased AU2006213922B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0502787.5 2005-02-10
GBGB0502787.5A GB0502787D0 (en) 2005-02-10 2005-02-10 Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
PCT/GB2006/000452 WO2006085079A2 (en) 2005-02-10 2006-02-09 Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use

Publications (3)

Publication Number Publication Date
AU2006213922A1 AU2006213922A1 (en) 2006-08-17
AU2006213922A2 AU2006213922A2 (en) 2006-08-17
AU2006213922B2 true AU2006213922B2 (en) 2011-09-29

Family

ID=34356109

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006213922A Ceased AU2006213922B2 (en) 2005-02-10 2006-02-09 Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use

Country Status (20)

Country Link
US (2) US20080206358A1 (enExample)
EP (2) EP3120855A1 (enExample)
JP (2) JP5328157B2 (enExample)
KR (3) KR20070082918A (enExample)
CN (2) CN105412150B (enExample)
AR (2) AR053678A1 (enExample)
AU (1) AU2006213922B2 (enExample)
BR (1) BRPI0606923B1 (enExample)
CA (1) CA2597124C (enExample)
ES (1) ES2599152T3 (enExample)
GB (1) GB0502787D0 (enExample)
IL (1) IL184448A (enExample)
MX (1) MX2007009688A (enExample)
MY (1) MY150070A (enExample)
NO (2) NO341846B1 (enExample)
NZ (1) NZ556600A (enExample)
RU (1) RU2420297C2 (enExample)
TW (1) TWI461201B (enExample)
WO (1) WO2006085079A2 (enExample)
ZA (1) ZA200706160B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) * 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) * 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
GB201005931D0 (en) 2010-04-09 2010-05-26 Isis Innovation Immune modulation
US9649335B1 (en) * 2016-03-30 2017-05-16 Baylor University Intravenous administration of an oxygen-enabled fluid
KR102036549B1 (ko) 2018-10-08 2019-10-25 (주)씨앤팜 활성성분을 포함하는 변성 다중층 수산화물 구조체를 포함하는 금속 수산화물 복합체 및 이의 제조 방법
EA202191134A1 (ru) 2018-10-25 2021-07-13 Эйрджен Фарма Лтд. Способы лечения смешанными металлосодержащими соединениями
MX2023004402A (es) * 2020-10-17 2023-10-12 David Anderson Formulacion y estabilizacion no covalente de derivados del acido olivetolico.
RU2758671C1 (ru) * 2020-12-08 2021-11-01 Федеральное государственное бюджетное учреждение науки Институт физики прочности и материаловедения Сибирского отделения Российской академии наук (ИФПМ СО РАН) СПОСОБ ПОЛУЧЕНИЯ НАНОСТРУКТУРНЫХ ДВОЙНЫХ ГИДРОКСИДОВ НА ОСНОВЕ АЛЮМИНИЯ И ЩЕЛОЧНОЗЕМЕЛЬНЫХ МЕТАЛЛОВ, ТАКИХ КАК МАГНИЙ ИЛИ КАЛЬЦИЙ, ОБЛАДАЮЩИХ СВОЙСТВОМ ПОВЫШАТЬ pH КЛЕТОЧНОЙ СРЕДЫ, И НАНОСТРУКТУРЫ, ПОЛУЧЕННЫЕ ДАННЫМ СПОСОБОМ

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629626A (en) * 1983-06-27 1986-12-16 Kyowa Chemical Industry Co., Ltd. Hydrothermally treated product of compound having hydrotalcite-like crystal structure composition thereof, and use thereof
WO1999015189A1 (en) * 1997-09-19 1999-04-01 Crosfield Limited Metal compounds, mixed or sulphated, as phosphate binders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2838930C2 (de) * 1978-09-07 1980-07-03 Chemische Werke Huels Ag, 4370 Marl Wäßriges Behandlungsmittel für Holz und Holzwerkstoffe und dessen Verwendung
US4514389A (en) * 1981-05-06 1985-04-30 Kyowa Chemical Industry Co. Ltd. Gastric antacid and method for controlling pH of gastric juice
US4566986A (en) * 1984-08-31 1986-01-28 Waldmann John J Flocculating agents and processes for making them
US5153156A (en) * 1989-04-18 1992-10-06 Aristech Chemical Corporation Process for making efficient anionic clay catalyst, catalysts made thereby, and method of making isophorone
US5246899A (en) * 1991-08-16 1993-09-21 Amoco Corporation Simplified preparation of hydrotalcite-type clays
NL9201907A (nl) * 1992-11-02 1994-06-01 Tno Peristaltisch mengende reactor en peristaltische kleppenpomp.
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
GB9506126D0 (en) * 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
WO2003003809A2 (en) * 2001-07-05 2003-01-16 Marantech Holding, Llc Methods of using electron active compounds for managing conditions afflicting mammals
RU2224713C2 (ru) * 2001-11-28 2004-02-27 Институт неорганической химии им. А.В.Николаева СО РАН (статус государственного учреждения) Способ получения нанокомпозитных материалов
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
JP4348426B2 (ja) 2002-08-29 2009-10-21 独立行政法人産業技術総合研究所 高選択性脱リン剤及びその製造方法
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
EP1696889A1 (en) * 2003-08-28 2006-09-06 Ranbaxy Laboratories, Ltd. Pharmaceutical compositions of benzimidazole and processes for their preparation
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629626A (en) * 1983-06-27 1986-12-16 Kyowa Chemical Industry Co., Ltd. Hydrothermally treated product of compound having hydrotalcite-like crystal structure composition thereof, and use thereof
WO1999015189A1 (en) * 1997-09-19 1999-04-01 Crosfield Limited Metal compounds, mixed or sulphated, as phosphate binders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TSUGIO SATO, TAKAYOSHI WAKABAYASHI MASAHIKO SHIMADA: IND. ENG. CHEM. PROD. RES. DEV., 1986, PAGES 89-92 *

Also Published As

Publication number Publication date
KR101491531B1 (ko) 2015-03-09
AU2006213922A1 (en) 2006-08-17
NZ556600A (en) 2010-02-26
KR20140066756A (ko) 2014-06-02
CA2597124A1 (en) 2006-08-17
BRPI0606923B1 (pt) 2019-06-18
MY150070A (en) 2013-11-29
CN101115490B (zh) 2015-12-09
US20120093943A1 (en) 2012-04-19
EP1850859A2 (en) 2007-11-07
NO20171769A1 (no) 2007-11-12
RU2420297C2 (ru) 2011-06-10
KR20070082918A (ko) 2007-08-22
MX2007009688A (es) 2008-01-22
EP1850859B1 (en) 2016-07-20
ZA200706160B (en) 2009-02-25
WO2006085079A2 (en) 2006-08-17
WO2006085079A3 (en) 2006-12-14
GB0502787D0 (en) 2005-03-16
CA2597124C (en) 2015-11-24
AU2006213922A2 (en) 2006-08-17
RU2007133720A (ru) 2009-03-20
KR20130121186A (ko) 2013-11-05
TWI461201B (zh) 2014-11-21
IL184448A0 (en) 2007-10-31
IL184448A (en) 2014-12-31
NO20074504L (no) 2007-11-12
ES2599152T3 (es) 2017-01-31
NO341846B1 (no) 2018-02-05
BRPI0606923A2 (pt) 2009-12-01
AR106699A2 (es) 2018-02-07
CN105412150B (zh) 2019-05-17
EP3120855A1 (en) 2017-01-25
JP2013209401A (ja) 2013-10-10
AR053678A1 (es) 2007-05-16
JP5328157B2 (ja) 2013-10-30
TW200640476A (en) 2006-12-01
JP2008530065A (ja) 2008-08-07
CN105412150A (zh) 2016-03-23
US20080206358A1 (en) 2008-08-28
CN101115490A (zh) 2008-01-30

Similar Documents

Publication Publication Date Title
US20120093943A1 (en) Pharmaceutically active compounds, their manufacture, compositions containing them, and their use
IL184720A (en) Ivandronate polymorph b, a process for its preparation and pharmaceutical preparations containing it
KR101552183B1 (ko) 고인산혈증의 치료를 위한 혼합 금속 화합물
JP6049801B2 (ja) 混合金属化合物
HK1142525B (en) Mixed metal compounds for treatment of hyperphosphataemia

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 11 JUL 2007

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: CYTOCHROMA DEVELOPMENT INC.

Free format text: FORMER OWNER WAS: INEOS HEALTHCARE LIMITED

MK14 Patent ceased section 143(a) (annual fees not paid) or expired